Efficacy News and Research

RSS
European Commission approves Pfizer's SUTENT for pancreatic neuroendocrine tumors

European Commission approves Pfizer's SUTENT for pancreatic neuroendocrine tumors

AVEO to present data on tivozanib Phase 1b trial for breast cancer at SABCS Symposium

AVEO to present data on tivozanib Phase 1b trial for breast cancer at SABCS Symposium

Anti-retroviral therapy yields 'Lazarus effect': Long-term household investment strategy replaces hopelessness

Anti-retroviral therapy yields 'Lazarus effect': Long-term household investment strategy replaces hopelessness

CSC files IND application to commence Phase I study for Spinal Muscular Atrophy

CSC files IND application to commence Phase I study for Spinal Muscular Atrophy

Research may lead to new treatment strategies for Graves' disease

Research may lead to new treatment strategies for Graves' disease

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Shire reports topline results from FAST-3 Firazyr Phase III trials for acute attacks of hereditary angioedema

Stemline to feature SL-401 clinical efficacy at ASH Annual Meeting

Stemline to feature SL-401 clinical efficacy at ASH Annual Meeting

FDA advisory committee votes against Avodart sNDA for prostate cancer risk reduction

FDA advisory committee votes against Avodart sNDA for prostate cancer risk reduction

Daiichi Sankyo completes patient enrollment in Phase III edoxaban study for AF

Daiichi Sankyo completes patient enrollment in Phase III edoxaban study for AF

Oramed announces publication of GLP-1 analog formulation in Journal of Diabetes

Oramed announces publication of GLP-1 analog formulation in Journal of Diabetes

Study reveals major findings of National Cancer Registry of Spain for Gastroenteropancreatic Neuroendocrine Tumours

Study reveals major findings of National Cancer Registry of Spain for Gastroenteropancreatic Neuroendocrine Tumours

Pfizer to present data on hematology portfolio at ASH Annual Meeting

Pfizer to present data on hematology portfolio at ASH Annual Meeting

PepTcell changes name to SEEK

PepTcell changes name to SEEK

New experimental device could offer effective treatment option for people with swallowing disorders

New experimental device could offer effective treatment option for people with swallowing disorders

Initial data from resminostat Phase II Hodgkin Lymphoma trial to be presented at 52nd ASH

Initial data from resminostat Phase II Hodgkin Lymphoma trial to be presented at 52nd ASH

Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting

Data on UCB’s anti-epileptic drugs to be presented at AES annual meeting

GenSpera expands G-202 Phase I safety trial to CTRC at University of Texas Health Science Center

GenSpera expands G-202 Phase I safety trial to CTRC at University of Texas Health Science Center

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

NSAID Celebrex may help prevent non-melanoma skin cancer development: Research

NSAID Celebrex may help prevent non-melanoma skin cancer development: Research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.